Prosecution Insights
Last updated: November 18, 2026
Application No. 18/255,023

BLOCK COPOLYMERS DERVIED FROM SHORT AND LONG ALKYL CHAIN ACRYLATES OR ACRYLAMIDES AND APPLICATIONS THEREOF

Final Rejection §101§103
Filed
May 30, 2023
Priority
Nov 30, 2020 — provisional 63/119,445 +2 more
Examiner
LEE, DORIS L
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Isp Investments LLC
OA Round
2 (Final)
59%
Grant Probability
Moderate
3-4
OA Rounds
68%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
642 granted / 1090 resolved
-6.1% vs TC avg
Moderate +9% lift
Without
With
+8.8%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
41 currently pending
Career history
1139
Total Applications
across all art units

Office Action

§101 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment No new grounds of rejection are set forth below. Thus, the following action is made final. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior office action. Claim Rejections - 35 USC § 103 Claim(s) 1-2, 4 and 7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Everaerts et al (US 2004/0097658). The rejection is adequately set forth in paragraph 8 of the Office Action mailed on March 30, 2026 and is incorporated here by reference. Double Patenting Claims 1-2, 4 and 7 are provisionally rejected under 35 U.S.C. 101 as claiming the same invention as that of claims 1-2, 4 and 7 of copending Application No. 18/558,920 (reference application). The rejection is adequately set forth in paragraph 10 of the Office Action mailed on March 30, 2026 and is incorporated here by reference. Response to Arguments The 35 USC 112(b) and 35 USC 112(d) rejections set forth in paragraphs 4 and 7 in the office action mailed on March 30, 2026 are withdrawn in light of applicant’s amendment filed on August 31, 2026. Applicants’ arguments filed August 31, 2026 regarding the prior art rejections have been fully considered but they are not persuasive for the reasons set forth below: Applicant’s argument: The rejection has used impermissible hindsight to arrive at the claimed subject matter. Examiner’s response: Only teachings within the Everaerts reference has been used. No teachings have been gleaned from applicant’s invention. Applicant’s argument: Everaerts does not teach all the elements of the claimed subject matter. Everaerts does not disclose the claimed arrangement of the claimed block A and block B. Most notably, the action cites paragraphs [0051] and [0061] as support for the N-octyl acrylamide. It is noted that [0061] refers to block B, but [0051] refers to block A. Examiner’s response: It is noted that in paragraph [0061], Everaerts teaches that the monomer can be a N-alkylated acrylamide. Paragraph [0051] is used only to teach what Everaerts considers to be an n-alkylated acrylamide, namely an n-octyl acrylamide which is appropriately used in block B. Applicant’s argument: Everaerts’ own disclosure teaches away from the block arrangement recited in the pending claims. Everaerts describes the A blocks as relatively high glass transition temperatures and B as relatively low glass transition temperature. Everaerts does not provide data or evidence that the specific block arrangement showing that the specific block arrangement would retain the desired phase behavior, glass transition temperature relationship, or other desired properties of Everaerts. Examiner’s response: It is noted that the claims do not have limitations regarding glass transition temperatures and Everaerts clearly teaches that the recited monomers are appropriate for each of the respective blocks as presently claimed. As the claims are written, the blocks are not necessarily comprised 100% of the recited repeating units, other types of monomers can be incorporated to meet the desired properties of Everaerts. Applicant’s argument: The applicant requests the double patenting rejection against 18/558,920 be withdrawn because applicant intends it to go abandoned. Examiner’s response: As the co-pending application has not yet been abandoned, the double patenting rejection above has been maintained. The examiner suggests filing an express abandonment in the copending application so that the intended abandonment is reflected in the prosecution record. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DORIS L LEE whose telephone number is (571)270-3872. The examiner can normally be reached M-F 8 am - 5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuther can be reached at 571-270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. DORIS L. LEE Primary Examiner Art Unit 1764 /DORIS L LEE/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

May 30, 2023
Application Filed
Mar 30, 2026
Non-Final Rejection mailed — §101, §103
Aug 31, 2026
Response Filed
Sep 15, 2026
Final Rejection mailed — §101, §103
Nov 13, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12780991
CONDENSATION-CURABLE SILICONE COMPOSITION, A CURED PRODUCT, AND A METHOD FOR PREPARING THE CURED PRODUCT
3y 3m to grant Granted Nov 03, 2026
Patent 12781048
POLY(PHENYLENE ETHER)-BASED COMPOSITION AND ARTICLE
2y 9m to grant Granted Nov 03, 2026
Patent 12767829
COLORANT, MASTER BATCH CONTAINING SAME, COLORED RESIN COMPOSITION, AND MOLDED ARTICLE
4y 0m to grant Granted Oct 20, 2026
Patent 12767797
ETHYLENE/ALPHA-OLEFIN INTERPOLYMER BASED COMPOSITIONS WITH EXCELLENT ADHESION PROPERTIES
3y 2m to grant Granted Oct 20, 2026
Patent 12753303
MODIFIED RESIN COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
3y 3m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
59%
Grant Probability
68%
With Interview (+8.8%)
Moderate
PTA Risk
Based on 1090 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month